Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 23/02/24

Trade details

Type
Insider sale
Amount
$577,749.05
Shares · price
2,335 sh · $247.43 a share
Held after
4,545 sh
Trade date
23/02/23
Filed
23/02/24
Days to filing
1 days

Sold 33.9% of holdings

Share of holding sold
33.9%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/24~23/03/25

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $220.2K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $218.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $153.5K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $131.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $114.8K

    Filed 10/01

Martine A. Rothblatt, Chairman — sold $577.7K of United Therapeutics UTHR · 33.9% of holdings | Whalegun